- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 109 x IOD: IODIDE ION(Non-functional Binders)
IOD.2: 2 residues within 4Å:- Chain A: H.23
- Ligands: IOD.3
Ligand excluded by PLIPIOD.3: 3 residues within 4Å:- Chain A: A.78, D.79
- Ligands: IOD.2
Ligand excluded by PLIPIOD.4: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.5: 2 residues within 4Å:- Chain A: I.24, R.27
Ligand excluded by PLIPIOD.6: 1 residues within 4Å:- Chain A: E.28
Ligand excluded by PLIPIOD.7: 1 residues within 4Å:- Chain A: E.44
Ligand excluded by PLIPIOD.8: 4 residues within 4Å:- Chain A: A.49, R.213, K.214, K.218
Ligand excluded by PLIPIOD.9: 1 residues within 4Å:- Chain A: F.51
Ligand excluded by PLIPIOD.10: 2 residues within 4Å:- Chain A: K.105
- Ligands: IOD.11
Ligand excluded by PLIPIOD.11: 5 residues within 4Å:- Chain A: S.80, K.105, H.254
- Ligands: IOD.10, IOD.12
Ligand excluded by PLIPIOD.12: 5 residues within 4Å:- Chain A: K.105, H.254, P.257, A.316
- Ligands: IOD.11
Ligand excluded by PLIPIOD.13: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.14: 1 residues within 4Å:- Chain A: R.365
Ligand excluded by PLIPIOD.15: 1 residues within 4Å:- Chain A: Y.277
Ligand excluded by PLIPIOD.16: 2 residues within 4Å:- Chain A: A.126, S.129
Ligand excluded by PLIPIOD.17: 4 residues within 4Å:- Chain A: E.140, R.141, S.166, K.167
Ligand excluded by PLIPIOD.18: 2 residues within 4Å:- Chain A: R.153, I.162
Ligand excluded by PLIPIOD.19: 2 residues within 4Å:- Chain A: D.160, P.233
Ligand excluded by PLIPIOD.20: 1 residues within 4Å:- Chain A: R.231
Ligand excluded by PLIPIOD.21: 3 residues within 4Å:- Chain A: T.185, D.186, G.242
Ligand excluded by PLIPIOD.22: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.23: 3 residues within 4Å:- Chain A: G.239, E.240, T.243
Ligand excluded by PLIPIOD.24: 5 residues within 4Å:- Chain A: S.289, D.290, Q.295
- Chain D: L.392
- Ligands: IOD.25
Ligand excluded by PLIPIOD.25: 3 residues within 4Å:- Chain A: D.290, Q.295
- Ligands: IOD.24
Ligand excluded by PLIPIOD.26: 3 residues within 4Å:- Chain A: R.389
- Chain D: Q.292
- Ligands: FDA.1
Ligand excluded by PLIPIOD.27: 3 residues within 4Å:- Chain A: D.300, K.304
- Chain D: R.384
Ligand excluded by PLIPIOD.28: 3 residues within 4Å:- Chain A: K.304
- Chain D: K.304, F.336
Ligand excluded by PLIPIOD.29: 3 residues within 4Å:- Chain A: R.318, F.328
- Chain D: E.306
Ligand excluded by PLIPIOD.30: 4 residues within 4Å:- Chain A: D.339, Q.374, Q.381, R.384
Ligand excluded by PLIPIOD.31: 3 residues within 4Å:- Chain A: Q.381, R.384
- Chain D: F.296
Ligand excluded by PLIPIOD.32: 2 residues within 4Å:- Chain A: E.377
- Ligands: FDA.1
Ligand excluded by PLIPIOD.34: 3 residues within 4Å:- Chain B: R.389
- Chain C: Q.292
- Ligands: FDA.33
Ligand excluded by PLIPIOD.35: 4 residues within 4Å:- Chain A: M.297
- Chain B: Q.381, R.384
- Chain C: F.296
Ligand excluded by PLIPIOD.36: 5 residues within 4Å:- Chain B: D.339, Q.374, N.380, Q.381, R.384
Ligand excluded by PLIPIOD.37: 2 residues within 4Å:- Chain B: K.304
- Chain C: K.304
Ligand excluded by PLIPIOD.38: 3 residues within 4Å:- Chain B: D.300, K.304
- Chain C: R.384
Ligand excluded by PLIPIOD.39: 3 residues within 4Å:- Chain B: D.290, Q.295
- Ligands: IOD.40
Ligand excluded by PLIPIOD.40: 5 residues within 4Å:- Chain B: S.289, D.290, Q.295
- Chain C: L.392
- Ligands: IOD.39
Ligand excluded by PLIPIOD.41: 2 residues within 4Å:- Chain B: E.377
- Ligands: FDA.33
Ligand excluded by PLIPIOD.42: 3 residues within 4Å:- Chain B: A.49, R.213, K.214
Ligand excluded by PLIPIOD.43: 3 residues within 4Å:- Chain B: H.23, I.24, R.27
Ligand excluded by PLIPIOD.44: 1 residues within 4Å:- Chain B: E.28
Ligand excluded by PLIPIOD.45: 3 residues within 4Å:- Chain B: E.22, H.23
- Ligands: IOD.46
Ligand excluded by PLIPIOD.46: 3 residues within 4Å:- Chain B: A.78, D.79
- Ligands: IOD.45
Ligand excluded by PLIPIOD.47: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.48: 1 residues within 4Å:- Chain B: R.365
Ligand excluded by PLIPIOD.49: 2 residues within 4Å:- Chain B: E.44, E.47
Ligand excluded by PLIPIOD.50: 1 residues within 4Å:- Chain B: E.44
Ligand excluded by PLIPIOD.51: 1 residues within 4Å:- Chain B: K.211
Ligand excluded by PLIPIOD.52: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.53: 4 residues within 4Å:- Chain B: K.105, H.254, A.316
- Ligands: IOD.54
Ligand excluded by PLIPIOD.54: 5 residues within 4Å:- Chain B: S.80, K.105, H.254
- Ligands: IOD.53, IOD.55
Ligand excluded by PLIPIOD.55: 3 residues within 4Å:- Chain B: K.105, M.109
- Ligands: IOD.54
Ligand excluded by PLIPIOD.56: 3 residues within 4Å:- Chain B: R.141, S.166, K.167
Ligand excluded by PLIPIOD.57: 4 residues within 4Å:- Chain B: T.185, D.186, P.241, G.242
Ligand excluded by PLIPIOD.58: 3 residues within 4Å:- Chain B: D.160, R.231, P.233
Ligand excluded by PLIPIOD.59: 1 residues within 4Å:- Chain B: Y.277
Ligand excluded by PLIPIOD.60: 2 residues within 4Å:- Chain B: R.318
- Chain C: E.306
Ligand excluded by PLIPIOD.61: 1 residues within 4Å:- Chain B: R.318
Ligand excluded by PLIPIOD.63: 3 residues within 4Å:- Chain B: R.384
- Chain C: D.300, K.304
Ligand excluded by PLIPIOD.64: 4 residues within 4Å:- Chain B: F.296
- Chain C: Q.381, R.384
- Chain D: M.297
Ligand excluded by PLIPIOD.65: 5 residues within 4Å:- Chain C: D.339, Q.374, N.380, Q.381, R.384
Ligand excluded by PLIPIOD.66: 4 residues within 4Å:- Chain B: Q.292
- Chain C: R.389
- Chain D: R.286
- Ligands: FDA.62
Ligand excluded by PLIPIOD.67: 3 residues within 4Å:- Chain C: E.142
- Chain D: R.281, K.282
Ligand excluded by PLIPIOD.68: 2 residues within 4Å:- Chain C: E.377
- Ligands: FDA.62
Ligand excluded by PLIPIOD.69: 3 residues within 4Å:- Chain B: E.306
- Chain C: R.318, F.328
Ligand excluded by PLIPIOD.70: 3 residues within 4Å:- Chain C: H.23, I.24, R.27
Ligand excluded by PLIPIOD.71: 1 residues within 4Å:- Chain C: E.28
Ligand excluded by PLIPIOD.72: 1 residues within 4Å:- Chain C: H.23
Ligand excluded by PLIPIOD.73: 1 residues within 4Å:- Chain C: R.365
Ligand excluded by PLIPIOD.74: 1 residues within 4Å:- Chain C: Y.277
Ligand excluded by PLIPIOD.75: 2 residues within 4Å:- Chain C: K.282, G.285
Ligand excluded by PLIPIOD.76: 3 residues within 4Å:- Chain C: A.49, R.213, K.214
Ligand excluded by PLIPIOD.77: 3 residues within 4Å:- Chain C: K.105, M.109
- Ligands: IOD.78
Ligand excluded by PLIPIOD.78: 5 residues within 4Å:- Chain C: S.80, K.105, H.254
- Ligands: IOD.77, IOD.79
Ligand excluded by PLIPIOD.79: 5 residues within 4Å:- Chain C: K.105, H.254, P.257, A.316
- Ligands: IOD.78
Ligand excluded by PLIPIOD.80: 1 residues within 4Å:- Chain C: T.243
Ligand excluded by PLIPIOD.81: 3 residues within 4Å:- Chain C: R.141, S.166, K.167
Ligand excluded by PLIPIOD.82: 3 residues within 4Å:- Chain C: T.185, D.186, G.242
Ligand excluded by PLIPIOD.83: 2 residues within 4Å:- Chain C: S.289, D.290
Ligand excluded by PLIPIOD.84: 1 residues within 4Å:- Chain C: R.389
Ligand excluded by PLIPIOD.86: 4 residues within 4Å:- Chain A: Q.292
- Chain C: R.286
- Chain D: R.389
- Ligands: FDA.85
Ligand excluded by PLIPIOD.87: 2 residues within 4Å:- Chain D: V.386, R.389
Ligand excluded by PLIPIOD.88: 2 residues within 4Å:- Chain D: S.289, D.290
Ligand excluded by PLIPIOD.89: 1 residues within 4Å:- Chain D: Y.277
Ligand excluded by PLIPIOD.90: 2 residues within 4Å:- Chain D: F.361, P.362
Ligand excluded by PLIPIOD.91: 4 residues within 4Å:- Chain A: F.296
- Chain C: M.297
- Chain D: Q.381, R.384
Ligand excluded by PLIPIOD.92: 5 residues within 4Å:- Chain D: D.339, Q.374, N.380, Q.381, R.384
Ligand excluded by PLIPIOD.93: 3 residues within 4Å:- Chain A: E.306
- Chain D: R.318, F.328
Ligand excluded by PLIPIOD.94: 1 residues within 4Å:- Chain D: R.27
Ligand excluded by PLIPIOD.95: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.96: 3 residues within 4Å:- Chain A: R.384
- Chain D: D.300, K.304
Ligand excluded by PLIPIOD.97: 3 residues within 4Å:- Chain C: R.281, K.282
- Chain D: E.142
Ligand excluded by PLIPIOD.98: 2 residues within 4Å:- Chain D: E.22
- Ligands: IOD.99
Ligand excluded by PLIPIOD.99: 3 residues within 4Å:- Chain D: A.78, D.79
- Ligands: IOD.98
Ligand excluded by PLIPIOD.100: 3 residues within 4Å:- Chain D: A.49, R.213, K.214
Ligand excluded by PLIPIOD.101: 1 residues within 4Å:- Chain D: K.211
Ligand excluded by PLIPIOD.102: 3 residues within 4Å:- Chain D: K.105, M.109
- Ligands: IOD.103
Ligand excluded by PLIPIOD.103: 3 residues within 4Å:- Chain D: K.105, H.254
- Ligands: IOD.102
Ligand excluded by PLIPIOD.104: 4 residues within 4Å:- Chain D: K.105, H.254, P.257, A.316
Ligand excluded by PLIPIOD.105: 2 residues within 4Å:- Chain D: E.377
- Ligands: FDA.85
Ligand excluded by PLIPIOD.106: 2 residues within 4Å:- Chain D: A.126, W.178
Ligand excluded by PLIPIOD.107: 4 residues within 4Å:- Chain D: E.140, R.141, S.166, K.167
Ligand excluded by PLIPIOD.108: 2 residues within 4Å:- Chain D: G.234, D.235
Ligand excluded by PLIPIOD.109: 4 residues within 4Å:- Chain D: D.160, R.231, I.232, P.233
Ligand excluded by PLIPIOD.110: 1 residues within 4Å:- Chain D: V.155
Ligand excluded by PLIPIOD.111: 3 residues within 4Å:- Chain D: T.185, D.186, G.242
Ligand excluded by PLIPIOD.112: 2 residues within 4Å:- Chain D: K.282, G.285
Ligand excluded by PLIPIOD.113: 2 residues within 4Å:- Chain D: E.44, E.47
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., SAD phasing using iodide ions in a high-throughput structural genomics environment. J.STRUCT.FUNCT.GENOM. (2011)
- Release Date
- 2010-11-10
- Peptides
- Acyl-CoA dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 109 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., SAD phasing using iodide ions in a high-throughput structural genomics environment. J.STRUCT.FUNCT.GENOM. (2011)
- Release Date
- 2010-11-10
- Peptides
- Acyl-CoA dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D